Fraser MacDonald
Directeur/Membre du Conseil chez PHARMALA BIOTECH HOLDINGS INC.
Fortune : 8 300 $ au 30/06/2024
Postes actifs de Fraser MacDonald
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Directeur/Membre du Conseil | 21/03/2021 | - |
| Independent Dir/Board Member | 21/03/2021 | - | |
Pharmala Biotech, Inc.
 Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Fraser MacDonald
Formation de Fraser MacDonald
| Queen's University | Undergraduate Degree |
| Bond University | Graduate Degree |
Statistiques
Internationale
| Canada | 4 |
| Australie | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Health Technology |
- Bourse
- Insiders
- Fraser MacDonald
- Expérience
